Financials
- Market Capitalization 387.76 M
- Employee 149
- Founded 2018
- CEO N/A
- Website www.kyvernatx.com
- Headquarter Delaware, United States
- FIGI BBG00RCYMHR1
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.58
売上高対価格比率
-6 934.07
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2988 | DRUG Bright Minds Biosciences Inc. - common stock | 54.47 USD | +0.78% | +8.14% | -13.31% | -11.24% | 415.92 M USD | ||
| 2993 | MPLT MapLight Therapeutics, Inc. - Common Stock | 8.82 USD | -0.11% | -5.26% | -32.57% | -53.58% | 409.05 M USD | ||
| 3015 | GALT Galectin Therapeutics Inc. - Common Stock | 3.92 USD | -0.51% | +6.52% | -0.76% | -18.67% | 395.33 M USD | ||
| 3023 | IRD Opus Genetics, Inc. - Common Stock | 4.66 USD | +0.22% | +6.64% | -22.59% | +25.27% | 387.69 M USD |